UT Health San Antonio Cancer Center, founded in 1974, is an NCI-designated Cancer Center in San Antonio, Texas. It is a component of the University of Texas Health Science Center, San Antonio which is located adjacently.

During the past decade, Mays Cancer Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mays Cancer Center" #1 sponsor was "The University of Texas Health Science Center at San Antonio" with 8 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Blueprint Medicines Corporation" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mays Cancer Center" #1 collaborator was "Arizona State University" with 1 trials as a collaborator, "Calm.com, Inc." with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Imago BioSciences,Inc." with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Mays Cancer Center" are "Prostate Cancer" (2 trials), "Accelerated/Blast-phase Myeloproliferative Neoplasm" (1 trials), "Advanced Cancers" (1 trials), "Advanced Systemic Mastocytosis" (1 trials) and "Advanced Unresectable or Metastatic Solid Malignancy" (1 trials). Many other conditions were trialed in "Mays Cancer Center" in a lesser frequency.

Most popular intervention types in "Mays Cancer Center" are "Drug" (22 trials), "Other" (4 trials), "Behavioral" (1 trials), "Combination Product" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (3 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials), "Placebo" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mays Cancer Center" are 23 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mays Cancer Center". undefined are not yet recruiting, 17 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mays Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mays Cancer Center, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".